Goldman Sachs
TELA icon

Goldman Sachs’s TELA Bio TELA Stock Holding History

Goldman Sachs’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-153,749
Closed -$723K – 6065
2024
Q2 		$723K Buy
153,749
+141,140
+1,119% +$744K ﹤0.01% 4617
2024
Q1 		$71.5K Buy
+12,609
New +$83.2K ﹤0.01% 5289
2023
Q2 		– Sell
-35,155
Closed -$374K – 6062
2023
Q1 		$374K Buy
+35,155
New +$388K ﹤0.01% 4994
2022
Q1 		– Sell
-19,662
Closed -$252K – 6904
2021
Q4 		$252K Sell
19,662
-3,558
-15% -$45.1K ﹤0.01% 5767
2021
Q3 		$317K Sell
23,220
-903
-4% -$12.6K ﹤0.01% 5465
2021
Q2 		$389K Buy
24,123
+3,605
+18% +$49.4K ﹤0.01% 5361
2021
Q1 		$306K Buy
20,518
+176
+0.9% +$2.65K ﹤0.01% 5422
2020
Q4 		$306K Sell
20,342
-10,344
-34% -$168K ﹤0.01% 4877
2020
Q3 		$508K Buy
+30,686
New +$431K ﹤0.01% 4473

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Goldman Sachs's TELA Position: Q3 2024 in Review

Goldman Sachs sold out of TELA Bio (TELA) in Q3 2024, closing a stake of 153,749 shares — an estimated $723K sold.

Goldman Sachs first reported a position in TELA in Q3 2020 and held it in 9 quarters. The position peaked at $723K in Q2 2024. 49 funds tracked by Wall St. Rank hold TELA as of Q3 2024.

  • Goldman Sachs reported no remaining TELA Bio position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 153,749 TELA Bio shares in Q3 2024, an estimated $723K.
  • Goldman Sachs first reported a position in TELA Bio in Q3 2020 and held it in 9 quarters.
  • Goldman Sachs's TELA Bio position peaked at $723K in Q2 2024.
  • 49 funds tracked by Wall St. Rank held TELA Bio as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.